| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 27 |
| 1 | ALENDRONATE SODIUM | 12 |
| 2 | BACLOFEN | 9 |
| 3 | ASPIRIN | 8 |
| 4 | ASPIRIN 325 MG | 8 |
| 5 | ASPIRIN 81 MG | 8 |
| 6 | ATORVASTATIN CALCIUM | 7 |
| 7 | LISINOPRIL | 7 |
| 8 | PREGABALIN | 7 |
| 9 | ACETAMINOPHEN | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RESLIZUMAB | 1 | 0.0015 |
| 1 | AVALGLUCOSIDASE ALFA-NGPT | 1 | 0.0010 |
| 2 | BACLOFEN INJECTION | 3 | 0.0010 |
| 3 | GINKGO BILOBA | 1 | 0.0007 |
| 4 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 1 | 0.0005 |
| 5 | CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE | 1 | 0.0005 |
| 6 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 7 | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | 1 | 0.0003 |
| 8 | CLINDAMYCIN HYDROCHLORIDE | 1 | 0.0003 |
| 9 | MARC GLASSMAN | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Skin Test Antigen [EPC] | 1 | 0.0005 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 12 | 0.0001 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 8 | Antimycobacterial [EPC] | 2 | 0.0001 |
| 9 | Integrin Receptor Antagonist [EPC] | 6 | 0.0001 |